Inventor · disambiguated record
David Porubek
Also filed as: PORUBEK DAVID · PORUBEK DAVID J
25 granted patents·2 pending applications·570 citations·filing 1984–2006
97Inventor score
Top patents by PatentIndex Score
27 records- 0191US6566354B1Method for treatment of bacterial infections with once or twice-weekly administered rifalazilKANEKA CORP·Filed 2001·Granted May 20, 2003·36 cites·12 claims
- 0291US5780476AHydroxyl-containing xanthine compoundsCELL THERAPEUTICS INC·Filed 1995·Granted Jul 14, 1998·95 cites·11 claims
- 0389US5648357AEnatiomerically pure hydroxylated xanthine compoundsCELL THERAPEUTICS INC·Filed 1994·Granted Jul 15, 1997·59 cites·10 claims
- 0486US6316433B1Method for treatment of bacterial infections with once or twice-weekly administered rifalazilKANEKA CORP·Filed 1999·Granted Nov 13, 2001·50 cites·16 claims
- 0586US5288721ASubstituted epoxyalkyl xanthinesCELL THERAPEUTICS INC·Filed 1992·Granted Feb 22, 1994·31 cites·12 claims
- 0678US5473070ASubstituted long chain alcohol xanthine compoundsCELL THERAPEUTICS INC·Filed 1992·Granted Dec 5, 1995·18 cites·12 claims
- 0777US5804584ATherapeutic compounds containing a monocyclic five- to six- membered ring structure having one to two nitrogen atomsCELL THERAPEUTICS INC·Filed 1995·Granted Sep 8, 1998·39 cites·9 claims
- 0875US5621102AProcess for preparing enantiomerically pure xanthine derivativesCELL THERAPEUTICS INC·Filed 1995·Granted Apr 15, 1997·22 cites·10 claims
- 0975US5620984AEnatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseasesCELL THERAPEUTICS INC·Filed 1995·Granted Apr 15, 1997·21 cites·3 claims
- 1075US5580873AEnatiomerically pure hydroxylated xanthine compounds to treat proliferative vascular diseasesCELL THERAPEUTICS INC·Filed 1995·Granted Dec 3, 1996·23 cites·3 claims
- 1173US5965564AEnantiomerically pure hydroxylated xanthine compoundsCELL THERAPEUTICS INC·Filed 1998·Granted Oct 12, 1999·19 cites·12 claims
- 1273US5739138AEnantiomerically pure hydroxylated xanthine compounds to treat autoimmune diabetesCELL THERAPEUTICS INC·Filed 1995·Granted Apr 14, 1998·19 cites·2 claims
- 1373US5629315ATreatment of diseases using enantiomerically pure hydroxylated xanthine compoundsCELL THERAPEUTICS INC·Filed 1995·Granted May 13, 1997·19 cites·5 claims
- 1472US5792772AEnatiomerically pure hydroxylated xanthine compoundsCELL THERAPEUTICS INC·Filed 1995·Granted Aug 11, 1998·18 cites·4 claims
- 1572US5354756AOlefin-substituted long chain xanthine compoundsCELL THERAPEUTICS INC·Filed 1993·Granted Oct 11, 1994·12 cites·12 claims
- 1670US6780865B1Compounds having selective hydrolytic potentialsCELL THERAPEUTICS INC·Filed 1997·Granted Aug 24, 2004·12 cites·21 claims
- 1769US6133274AHydroxyl-containing bicyclic compoundsCELL THERAPEUTICS INC·Filed 1996·Granted Oct 17, 2000·26 cites·13 claims
- 1866US6693105B1Hydroxyl-containing compoundsCELL THERAPEUTICS INC·Filed 1999·Granted Feb 17, 2004·11 cites·18 claims
- 1964US7772228B2Method for treatment of bacterial infections with once or twice-weekly administered rifalazilKANEKA CORP·Filed 2002·Granted Aug 10, 2010·1 cites·4 claims
- 2063US5567704AR-enatiomerically pure hydroxylated xanthine compounds to treat baldnessCELL THERAPEUTICS INC·Filed 1995·Granted Oct 22, 1996·7 cites·4 claims
- 2159US7053096B2Compounds having selective hydrolytic potentialsCELL THERAPEUTICS INC·Filed 2004·Granted May 30, 2006·1 cites·19 claims
- 2258US2006211713A1Compounds having selective hydrolytic potentialsCELL THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 2357US5580874AEnatiomerically pure hydroxylated xanthine compoundsCELL THERAPEUTICS INC·Filed 1995·Granted Dec 3, 1996·14 cites·4 claims
- 2452US2003207901A1Hydroxyl-containing compoundsCELL THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 2549US5612349AEnantiomerically pure hydroxylated xanthine compounds to treat shock symptomsCELL THERAPEUTICS INC·Filed 1995·Granted Mar 18, 1997·4 cites·4 claims
- 2648US4745109ASuicide inhibitors of aromataseWASHINGTON RES FOUND·Filed 1984·Granted May 17, 1988·8 cites·18 claims
- 2743US5521315AOlefin substituted long chain compoundsCELL THERAPEUTICS INC·Filed 1993·Granted May 28, 1996·5 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →